ES8304068A1 - Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro. - Google Patents

Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.

Info

Publication number
ES8304068A1
ES8304068A1 ES511335A ES511335A ES8304068A1 ES 8304068 A1 ES8304068 A1 ES 8304068A1 ES 511335 A ES511335 A ES 511335A ES 511335 A ES511335 A ES 511335A ES 8304068 A1 ES8304068 A1 ES 8304068A1
Authority
ES
Spain
Prior art keywords
retro
procedure
cyclic
preparation
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511335A
Other languages
English (en)
Spanish (es)
Other versions
ES511335A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8304068A1 publication Critical patent/ES8304068A1/es
Publication of ES511335A0 publication Critical patent/ES511335A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES511335A 1981-04-13 1982-04-08 Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro. Granted ES511335A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/254,010 US4360516A (en) 1981-04-13 1981-04-13 Modified D-retro cyclic hexapeptide somatostatin analogs

Publications (2)

Publication Number Publication Date
ES8304068A1 true ES8304068A1 (es) 1983-02-16
ES511335A0 ES511335A0 (es) 1983-02-16

Family

ID=22962578

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511335A Granted ES511335A0 (es) 1981-04-13 1982-04-08 Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.

Country Status (9)

Country Link
US (1) US4360516A (OSRAM)
EP (1) EP0063308B1 (OSRAM)
JP (1) JPS57179142A (OSRAM)
AT (1) ATE14439T1 (OSRAM)
DE (1) DE3264861D1 (OSRAM)
DK (1) DK159382A (OSRAM)
ES (1) ES511335A0 (OSRAM)
GR (1) GR75544B (OSRAM)
PT (1) PT74720B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427661A (en) * 1982-07-30 1984-01-24 Merck & Co., Inc. Fluorinated cyclic hexapeptide somatostatin analogs
CH655505B (OSRAM) * 1982-08-24 1986-04-30
DE3303345A1 (de) * 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
US4508711A (en) * 1983-04-18 1985-04-02 American Cyanamid Company Cyclic pentapeptide displaying somatostatin antagonism and method of treatment of mammals therewith
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4612366A (en) * 1985-06-17 1986-09-16 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
WO1992013958A1 (en) * 1991-02-06 1992-08-20 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
DE69229436T2 (de) * 1991-02-08 1999-11-25 Biomeasure, Inc. Verwendung von somatostatinanalogen zur behandlung von melanomen
US5811512A (en) * 1991-08-22 1998-09-22 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics and related cyclic hexapeptides
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
AU7655098A (en) 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for decreasing body weight
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US7026289B2 (en) * 1997-05-13 2006-04-11 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Method and compositions for treating hyperlipidemia and other conditions
PT980253E (pt) * 1997-05-13 2004-08-31 Conseils De Rec Appl Scient S Somatostatina e agonistas de somatostatina para tratar a insensibilidade a insulina e a sindrome x
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
CN101481405A (zh) 2001-06-08 2009-07-15 研究及应用科学协会股份有限公司 生长激素释放抑制因子-多巴胺嵌合类似物
JP4578470B2 (ja) 2003-04-22 2010-11-10 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ソマトスタチンベクター
AU2009259034B2 (en) 2008-06-12 2013-10-31 Ipsen Bioinnovation Limited Suppression of cancers
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
WO2014197938A1 (en) 2013-06-13 2014-12-18 Antisense Therapeutics Ltd Combination therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1101843A (en) * 1976-08-02 1981-05-26 Daniel F. Veber Cyclic hexapeptides useful for increasing feed efficiency
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4190648A (en) * 1979-03-13 1980-02-26 Merck & Co., Inc. Peptides having somatostatin activity
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
NZ195303A (en) * 1979-10-31 1984-10-19 Merck & Co Inc Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions

Also Published As

Publication number Publication date
DK159382A (da) 1982-10-14
JPS57179142A (en) 1982-11-04
EP0063308A1 (en) 1982-10-27
PT74720B (en) 1985-01-08
US4360516A (en) 1982-11-23
ES511335A0 (es) 1983-02-16
DE3264861D1 (en) 1985-08-29
ATE14439T1 (de) 1985-08-15
PT74720A (en) 1982-05-01
EP0063308B1 (en) 1985-07-24
GR75544B (OSRAM) 1984-07-27
JPH0360839B2 (OSRAM) 1991-09-17

Similar Documents

Publication Publication Date Title
ES8304068A1 (es) Un procedimiento para la preparacion de un compuesto hexapeptido ciclico d-retro.
NL7415786A (nl) Menginjectiespuit met twee kamers.
ES2078905T3 (es) Nuevos compuestos heterociclicos condensados y su utilizacion para medicamentos.
IT1229190B (it) Aumentato recupero di petrolio mediante iniezione ciclica di prodotti chimici fluorurati.
ES2118708T3 (es) Composiciones de piperidina y su preparacion y utilizacion.
ES2076841T3 (es) Procedimiento para la preparacion de metilclorosilanos.
FR2534489B1 (fr) Reacteur utilisable, notamment dans les experiences chimiques
ES551434A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
RO67158A (ro) Procedeu pentru separarea unor hidrocarburi aromatice din amestecuri care le contin
IT1079275B (it) Confezione contenente una composizione per il trattamento di tessuti e procedimento per tale trattamento
IT1143757B (it) Composti ciclici derivati dal tiopene,procedimento per la loro preparazione e loro impiego farmaceutico
ES8305702A1 (es) Un procedimiento para la preparacion de hexapeptido ciclico.
BE848260A (fr) Purification de la caprolactame,
DK139659B (da) Fremgangsmåde til fremstilling af gamma-globuliner til intravenos indgivelse.
IT8347666A0 (it) Derivati del benzotiofene, loro preparazione e loro impiego come medicamenti
FR1294M (fr) Procédé de fabrication de n-arylsulfonyl-n'-(2,5-endométhylene-1,2,5,6-tétrahydrobenzyl)-urées.
IT8621434A0 (it) Composti politriazinici contenenti gruppi piperidinilammidinici e loro impiego come stabilizzanti per polimeri.
NL169035C (nl) Chemische compressiereactor met vrij bewegende zuiger.
MX145854A (es) Procedimiento mejorado para la separacion del 4,4'-diaminodifenilmetano de una mezcla que contiene el isomero 2,4'
FR3300M (fr) Médicament ayant notamment une action hypotensive, contenant un composé sulfamylique.
FR1429976A (fr) Procédé de polymérisation de lactames contenant plus de six maillons
ES8303325A1 (es) "procedimiento para la preparacion de prostaglandinas".
FR1407813A (fr) Procédé cyclique, en phase vapeur, de séparation d'oléfines à chaîne droite
AR202156A1 (es) Procedimiento para el tratamiento con amoniaco liquido de fibras poliamidicas naturales
YATSUZUKA Rearing of the zoea of the blue crab (Neptunus pelagicus L.)